cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1999; 33:1519-1527
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nørgaard, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nørgaard, B. L.

Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring

Bjarne L. Nørgaard, MDa, Karl Andersen, MD*, Mikael Dellborg, MD*, Putte Abrahamsson, MD*, Jan Ravkilde, MDa, Kristian Thygesen, MD, FACCa for the TRIM study group

a Department of Medicine and Cardiology, Aarhus University Hospital, Aarhus, Denmark
* Department of Medicine and Cardiology, Sahlgrenska University Hospital, Ôstra, Gothenburg, Sweden



View larger version (69K):

[in a new window]
 
Figure 1 Top, Trend curve of ST vector magnitude (ST-VM) from a patient with unstable angina as displayed by the vectorcardiography monitoring system. Transient increases of ST-VM ≥50 µV from the baseline >1 min indicate episodes of myocardial ischemia. Bottom, 12-lead ECG tracings recorded at baseline (1) and during an episode of transient myocardial ischemia (2) as indicated on the trend curve.

 


View larger version (11K):

[in a new window]
 
Figure 2 Occurrence of cardiac death or AMI during 30 days of follow-up according to the level of cardiac troponin T and the presence or absence of ST segment episodes at continuous vectorcardiography ST segment monitoring. Top, Kaplan Meier curves of event-free probability of patients (n = 231) with troponin T <0.20 µg/liter or troponin T ≥0.20 µg/liter at inclusion (log rank test, p = 0.0006). Bottom, Kaplan Meier curves of event-free probability of patients (n = 214) without or with one ST segment (ST-VM) episode or more at continuous ST segment monitoring within 24 h of inclusion (log rank test, p = 0.0001). ST-VM = ST vector magnitude.

 


View larger version (18K):

[in a new window]
 
Figure 3 Flow of patients according to the level of cardiac troponin T at inclusion (cut-off value 0.20 µg/liter), the presence or absence of ST segment (ST-VM) episodes at continuous vectorcardiography ST segment monitoring within 24 h of inclusion, and event rate (cardiac death or myocardial infarction) after 30 days of follow-up. In 18 patients, no cVST analysis was performed due to the presence of bundle branch block, <16 h of cVST performed or because of technical problems. cTnT = cardiac troponin T. ST-VM = ST vector magnitude.

 




 
  cardiology careers collections past issues search home